Celcuity Inc.CELC

NASDAQHealthcareBiotechnology$114.22+3.11%

A clinical-stage biotechnology company focused on developing targeted therapies for cancer driven by specific molecular pathways. Its lead program, gedatolisib, is being studied in late-stage trials for hormone receptor–positive, HER2‑negative breast cancer, targeting the PI3K/AKT/mTOR signaling pat...

Market Cap: $5.3B52W Range: $7.58 – $120.31

This page tracks all publicly disclosed congressional trades in Celcuity Inc. (CELC), a company in the Healthcare sector. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.

Total Disclosures

Unique Politicians

Buys

Sells

Congressional Trading History

No congressional trades found for this stock.

All stocks traded by Congress Full trade feed Most active traders About the STOCK Act Report missing trade

Celcuity Inc.CELC

Congressional Trading History

Related